- Sections
- C - Chimie; métallurgie
- C07D - Composés hétérocycliques
- C07D 333/64 - Atomes d'oxygène
Détention brevets de la classe C07D 333/64
Brevets de cette classe: 92
Historique des publications depuis 10 ans
|
5
|
5
|
8
|
10
|
10
|
9
|
7
|
7
|
8
|
0
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| The Board of Trustees of the University of Illinois | 2623 |
13 |
| Novartis AG | 11238 |
9 |
| BioCryst Pharmaceuticals, Inc. | 170 |
5 |
| Merck Patent GmbH | 5909 |
4 |
| Radius Pharmaceuticals, Inc. | 63 |
4 |
| Genzyme Corporation | 1205 |
3 |
| Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | 83 |
3 |
| Bayer Pharma AG | 1096 |
2 |
| Board of Regents, The University of Texas System | 5370 |
2 |
| Antabio SAS | 23 |
2 |
| Arcus Biosciences, Inc. | 107 |
2 |
| Bionomics Limited | 90 |
2 |
| Cayman Chemical Company, Incorporated | 72 |
2 |
| G1 Therapeutics, Inc. | 128 |
2 |
| JNC Corporation | 1527 |
2 |
| JNC Petrochemical Corporation | 425 |
2 |
| Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 762 |
2 |
| Nikang Therapeutics, Inc. | 73 |
2 |
| Merck Sharp & Dohme Corp. | 2247 |
1 |
| Takeda Pharmaceutical Company Limited | 2961 |
1 |
| Autres propriétaires | 27 |